Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-20
2009-11-03
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S228200, C514S248000, C544S058200, C544S062000, C544S117000, C544S236000
Reexamination Certificate
active
07612067
ABSTRACT:
The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
REFERENCES:
patent: 7105550 (2006-09-01), Love et al.
patent: 1 364 952 (2003-11-01), None
patent: 1 466 527 (2004-10-01), None
patent: WO 97/29109 (1997-08-01), None
Sabino, Psychopharmacology (2006) 189:175-186.
Moreau, S., et al., Synthesis and anticonvulsant Properties of Triazolo- and Imidazopyridazinyl Carboxamides and Carboxylic Acids, Bioorganic & Medicinal Chemistry, Elsevier Science Ltd., GB, vol. 6, No. 7, 1988, pp. 983-991.
Barbosa Heather Janelle
Collins Elizabeth Aaron
Hamdouchi Chafiq
Hembre Erik James
Hipskind Philip Arthur
Eli Lilly and Company
Hostettler Danica
Jaisle Cecilia M
Tucker R. Craig
Wilson James O
LandOfFree
Imidazopyridazine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridazine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridazine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4130184